Cartesian Therapeutics board member Scott D. Myers resigns effective Nov 21, 2023; not due to disagreement

Cartesian Therapeutics, Inc.

Scott D. Myers resigned from the Board of Directors effective November 21, 2023.
Resignation was to pursue other opportunities and not due to any disagreement with the Company.
Myers also ceased service on the Compensation and Nominating and Corporate Governance Committees.
The Company thanked Myers for his service since joining the board in June 2019.
No replacement was announced; ticker RNAC listed on Nasdaq.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Scott D. Myers

member of the Board of Directors

RNAC · Cartesian Therapeutics, Inc.

Effective: 2023-11-21
Filed: November 27, 2023, 6:59 PM ET

On November 21, 2023, Scott D. Myers, a member of the Board of Directors (the “Board”) of Cartesian Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, effective immediately, to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott D. Myers resigned as member of the Board of Directors at Cartesian Therapeutics, Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On November 21, 2023, Scott D. Myers, a member of the Board of Directors (the “Board”) of Cartesian Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, effective immediately, to pursue other opportunities.

View on SEC.gov

Cartesian Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001453687-23-000091

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.